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Abstract
Even with the prevalence of wounds, the medical technol‐
ogy for efficiently managing skin damage is still primitive.
The disruption of any of the numerous healing processes
can lead to problems in the time-sensitive healing actions
of the dermal and epidermal layers. Bacterial infection is
one of the major obstacles to proper wound healing as it
poses a danger of causing long-term negative effects.
Keeping the wound free of bacteria is imperative to the
proper and hasty repair of dermal wounds. Silver has been
widely used to treat wounds for its bactericidal properties.
Although the mechanism of silver’s antibacterial action is
not fully understood, it exhibits a significant antimicrobial
efficacy against a wide spectrum of bacterial species. A
number of different approaches to the mechanism are
reported and presented in this review. Silver nanoparticles
(AgNPs) have been reported to exhibit enhanced antibac‐
terial activity due to their increased surface-area-to-volume
ratio. AgNPs are capable of various modifications, signifi‐
cantly broadening the therapeutic properties of the mate‐
rial as a result. This review explores the different aspects of
silver and silver nanoparticles, and their antibacterial
properties, which can be applied in the field of wound
treatments.
Keywords wound treatment, antibacterial, silver, silver
nanoparticles
1. Introduction
The process of evolution leading to life on dry land may
have been significantly influenced by the development of
skin, acting as a barrier preventing water loss [1]. Water is
essential to all life forms on earth and the slightest change
in the water level of any organism can bring harm to its
host. Thus, the skin’s role in the maintenance of a healthy
body water is vital to survival on land. The skin, the largest
external organ in the human body, accounts for about 16%
of the adult human body [2]. The composition of the skin
is intricate, involving multi-faceted layers responsible for
various functions. There are two major components of the
skin: the epidermis and the dermis. The epidermis, covered
with keratin, is responsible for the physical, biochemical/
chemical and adaptive immunological barrier functions [3].
Skin damage is such a common occurrence in daily life that
its effects are passed over as negligible; however, in reality,
it poses a threat to the security of the entire body, especially
in unhygienic areas. The human body can experience a
variety of injuries, including penetration, burns, and blunt
trauma [4]. Some of these forms of damage can turn into
chronic wounds, which cause long-term agony and
complications in many patients, as a result of the inability
of the body to properly heal itself. Dermal reparation is an
elaborate process entailing the precise synchronization of
countless components of the skin to fix damaged tissues,
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restore protective barrier function, and re-establish the
homeostatic equilibrium state of the wound area [4]. The
steps of wound repair can be categorized into haemostasis,
inflammation, proliferation, and remodelling, with each
phase involving the collaborative work of many tissues and
cells [5]. Keratinocytes, fibroblasts, endothelial cells,
macrophages, and platelets cells are among the essential
cells involved in wound repair [6]. Haemostasis is charac‐
terized as the release of blood components into the injury
site, allowing the platelets to come into contact with the
exposed collagen and other components of the extracellular
matrix. This release then triggers the release of clotting
factors, essential growth factors, and cytokines such as
platelet-derived growth factor (PDGF) and transforming
growth factor (TGF-β), from the platelets [4]. During
haemostasis, platelets adhere to the wound site, where they
aggregate. Aggregation is then followed by coagulation
cascade activation, which results in the formation of
platelet clots in a protein mesh composed of cross-linked
fibrin [7]. The inflammation stage involves neutrophils
entering the injured area and beginning phagocytosis, in
order to remove unwanted substances, bacteria, and
unhealthy tissue. Macrophages also contribute to the
phagocytosis process by further releasing PDGF and TGF-
β during inflammation [4]. The sheer number of growth
factors and cytokines involved in the overall wound
healing task, including fibroblast growth factor, vascular
endothelial growth factor, granulocyte-macrophage
colony-stimulating factor, platelet-derived growth factor,
connective tissue growth factor, interleukin, and tumour
necrosis factor-alpha, indicates the complexity and fragility
of the process [6]. The cytokines and growth factors
released during the haemostasis and inflammation phases
act as chemical signals that control matrix production, cell
migration, differentiation, and enzyme expression.
Through these chemical signals, new blood supplies and
connective tissue cells are summoned into the damaged
area. After the inflammation phase, fibroblasts migrate to
the wound site and initiate the proliferative phase by
releasing fresh extracellular matrices. The released matri‐
ces are then cross-linked and reorganized during the
remodelling stage. Each step of the process must be carried
out appropriately in a timely manner, in order for the
wounded area to retrieve its homeostatic equilibrium. Any
disruptions in the process may lead to undesirable condi‐
tions that may present more serious problems at the wound
site. Thus, it is critical for the health of the patient that the
processes involved in the healing of dermal damage are not
disrupted.
The bacterial infection of wounds is one of the major
concerns in wound treatment. Chronic wounds, a major
cause of morbidity, are an example of a condition resulting
from bacterial infection [8]. The clinical spectrum of wound
colonization and infection describes the stages of bacterial
interaction with a wound: contamination, colonization,
local infection/critical colonization, the spreading of
invasive infection, and septicaemia [8]. Each stage of
infection produces various effects on the injury site, making
it difficult to understand the interaction of bacteria with the
disruption of wound healing. Biofilms—self-secreted
extracellular polysaccharide matrices—provide protection
for bacteria, through benefits such as increased infection
rates, substrate accessibility, metabolic efficiency, and
resilience towards environmental stress, along with
inhibitors of agents that remove or terminate bacteria [9].
Thus, the presence of biofilms further complicates the
interaction between dermal injury and bacteria. Chronic
wounds and delayed wound repair are often characterized
by elongated inflammation, faulty re-epithelialization, and
poor matrix remodelling [8]. A proliferation of microor‐
ganisms at the injury site can disrupt the healing processes
in a variety of ways. Thus, preventative measures for
inhibiting the growth of harmful microorganisms can be an
effective and straightforward course of action to help
remove all the possible disruptions that bacteria may
produce.
Silver is often utilized as an antibacterial agent, in order to
provide a sanitary environment for the wound healing
process. Silver was considered, historically, as one of the
most frequently used antibacterial substances before the
invention of antibiotics [10]. Silver was used in sutures to
prevent postoperative inflammation and infections when
treating battle wounds during the First World War [11]. The
use of antibiotics, metal ions, enzymes, and quaternary
ammonium compounds can exhibit negative side effects:
antibiotic resistance, environmental damage, and high
costs [12]. Such downsides have encouraged the scientific
community to look to other modes of bactericidal activity.
The multiplicity of silver’s bactericidal mechanisms gives
it a wide range of effective applications in the inhibition of
bacterial growth. Utilizing broad-spectrum antimicrobial
silver in wound treatment, to prevent the initial growth of
any bacteria, may contribute to the advancement of wound
treatment systems by providing an ideal sanitary environ‐
ment for maximum wound repair. The introduction of
nanoparticles has allowed the scientific community to
enhance the antibacterial properties of silver. The increased
surface area of the nanoparticles in turn induces an
increased rate of interaction between the test subjects and
the ionic silver. The increase in bactericidal efficiency
lowers the minimum inhibitory concentration, meaning
that a lower concentration of the material may be incorpo‐
rated into wound healing systems to exert the same degree
of effect. A lower concentration of silver nanoparticles will
reduce the possible interference of biological and chemical
wound healing processes from the AgNPs themselves.
Additionally, the modification capability of silver nano‐
particles further enhances its utilitarian spectrum in skin
reparation. This review paper explores recent studies to
provide an overview of the development of technologies
utilizing silver’s antibacterial activity in wound care.
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2. Silver in Wound Treatment
The mechanism of silver’s antibacterial activity has been
widely studied, in order to further understand its under‐
lying process. Before now, it was already understood that
silver’s mode of bactericidal action involves numerous
pathways. Silver atoms attach themselves to the thiol
groups of enzymes involved in vital biological processes,
including ion transport and transmembrane energy
generation [13]. Silver catalyzes oxidation reactions
between the oxygen and hydrogen atoms of the thiol,
producing disulfide bonds and inhibiting bacterial growth
[14]. Changes in the biologically vital molecules of cells lead
to changes in the cellular structure, which can cause
malfunctions and ultimately celldeath. Another mecha‐
nism of the antibacterial activity of silver is the disruption
of bacterial cell respiration. Silver ions are capable of
deactivating 30S ribosomal subunits. The deactivation of
the ribosome complex results in an interference in the
translation of proteins, a crucial part of bacterial reproduc‐
tion [15]. Succinyl-coenzyme A synthase is a crucial
component of the TCA cycle and catalyzes the reaction that
yields succinate from succinyl-CoA, while simultaneously
phosphorylating ADP to produce ATP [16]. Silver ions are
able to deactivate Succinyl-coenzyme A synthase, render‐
ing a certain ratio of the enzymes useless. Fructose biphos‐
phate adolase, which is deactivated by the presence of
silver ions, acts as the catalyst in the fructose-1,6,-bisphos‐
phate cleavage reaction that yields glyceraldehyde 3-
phosphate and dihydroxyacetone phosphate [16]. MalK, a
maltose transporter, is another protein greatly affected by
silver ions. After treating cells with 900 ppb Ag+ solution,a
decrease in their expression of 30S ribosomal subunit
protein, succinyl coenzyme A synthetase, maltose trans‐
porter, and fructose biphosphate adolase was observed,
supporting silver’s ability to disrupt multiple processes
involved in cell respiration [15]. Ag+ ions have been
reported to enter cells and denature DNA molecules by
disrupting the hydrogen bonds between purine and
pyrimidine base pairs [13]. Utilizing its antimicrobial
properties, silver has been increasingly integrated into
many wound treatments for burns, traumatic wounds,
diabetic ulcers, and chronic wounds. The lack of a normal
protection barrier,due to the presence of a wound, may lead
to an increase in the chance of infection and further
complications [17]. There is a wide variety of commercially
available wound dressings containing silver,which act as a
temporary protection barrier and provide ideal conditions
for effective repair [18]. The antibacterial activity of silver
ions is commonly tested on Gram-positive Staphylococcus
aureus (S. aureus) and Gram-negative Escherichia coli (E.
coli). Silver sulfadiazine (AgSD) is considered the gold
standard in terms of the antibacterial activity of silver ions
[19]. One comprehensive study of AgSD, regarding the
mechanism of its action on burn wound infections, inves‐
tigated the binding of silver ions and sulfadiazine (SD) to
the bacterial cells, the dissociation of AgSD, reactions
between AgSD and biologically significant components,
and the synergistic effects of sodium sulfadiazine and
AgSD. The results clearly indicate the lack of SD cell
penetration, meaning that this is unlikely to be a compo‐
nent in the antibacterial activity of AgSD [17]. Thus, it can
be inferred that the silver ions from the AgSD are solely
responsible for its ability to inhibit bacterial growth.
Additionally, the level of silver cellular binding of AgSD
was compared to that of various silver salts, to investigate
the dissociation rates that eventually yield the antibacterial
silver ions. AgSD and AgNO3 showed maximum silver
binding, while other silver compounds showed minimal
uptake, due to their slow dissociation rates. In a mechanis‐
tic study, E. coli and S. aureus cultures were exposed to a 10
μg/ml AgNO3 solution by adding the solution directly into
the medium [20]. The cells were then studied via transmis‐
sion electron microscopy (TEM) and X-ray microanalysis.
Feng et al. observed significant structural changes in both
bacterial species. Within the AgNO3 treated group, elec‐
tron-light regions were observed in the middle section of
the cells. Particles of condensed substances and electron
granules - aggregates of high-electron-density mass
consisted of silver and protein depositions observed in
TEM and SEM -were present throughout the cell structures
in both cell types, and severe cell wall damage was seen in
many E. coli cells. The X-ray microanalysis results affirmed
the presence of silver, sulfur and phosphorus within the
cells. The presence of phosphorus may be a result of
damage to the DNA molecules. From these results, it can
be inferred that the silver ions inflict a significant amount
of structural damage to the cells, possibly enough to be
considered lethal. The antimicrobial activity of silver is
often utilized in wound care systems with multiple assets.
One study of partial-thickness burn wound patients
clinically explored the wound-healing properties of Askina
Calgitrol Ag®, an alginate silver wound dressing, com‐
pared with those of 1% silver sulfadiazine, a substance
commonly used as the standard for antimicrobial proper‐
ties [21]. Sixty-five patients were randomly divided into
two experiment groups:35 patients were treated with 1%
AgSD and the remaining patients were treated with Askina
Calgitrol Ag®. The experimental group exhibited improved
efficacies in the following parameters: healing time,
nursing time, pain score, and number of wound dressing
changes. All determined parameter values were signifi‐
cantly lower in the Askina Clagitrol Ag® group. From these
results, it can be inferred that the alginate silver wound
dressing is much more effective in treating burn victims
than the simple AgSD solution, most likely due to the
presence of the wound exudate-like environment provided
by the alginate-based product. Furthermore, the biopoly‐
mer matrix containing silver ions may afford an improved
method of silver ion production at the wound site, which
may lead to additional increases in the level of interaction
between the silver ions and the microbes. The shorter
healing time and fewer dressing changes exhibited in the
experiments could also help significantly reduce the cost of
wound care, which is beginning to become a major eco‐
nomic problem worldwide.
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Even with the clinically tested effectiveness of the silver
ions, the development and application of such chemother‐
apy should proceed with caution, as previously unforeseen
side effects may present themselves under certain condi‐
tions. The limited efficiency of silver ion release, the
confined number of silver species, the inability of silver ions
to reach the wound bed, and the rapid consumption of
silver ions may necessitate higher concentrations of silver
compounds within the wound treatment systems, which
could be lethal to healthy host cells [19]. Thus, other modes
of silver ion delivery were sought, in order to increase the
efficiency of the wound healing treatments.
3. Silver Nanoparticles
The utilization of silver nanoparticles to increase the
surface-to-volume ratio has been reported to be successful
in enhancing the bactericidal efficiency of the silver ions.
The surface-to-volume ratio improvement is accompanied
by an increase in contact area with the bacteria. In order for
the silver to exhibit its antibacterial activity, it needs to be
in its ionic form. Thus, the increase in the contact area of
the nanoparticles is able to generate more silver ions able
to interact with the bacteria, so as to damage them via its
multiple pathways [22]. For the reasons provided, silver
nanoparticles have been garnering a great deal of attention
in the field of wound care systems.
Silver  nanoparticles  take  similar  approaches  to  killing
bacteria.  The  nano  scale  of  the  particles  is  their  major
advantage  in  the  improvement  of  their  efficiency.  The
antibacterial  activity  of  the silver  nanoparticles,  and its
mechanism  of  action,was  studied  by  analysing  the
membrane  permeability,  structural  morphology,  and
growth of E. coli  [23]. Li’s group gathered data proving
an increase  in  the  leakage of  reducing saccharides  and
proteins. The detected concentration of leaked reducing
sugars increased from 30 μg/mg to 102.5 μg/mg in two
hours,  and  the  leaked  protein  concentration  increased
from 5.89 μg/mg to 11.96 μg/mg in four hours. The rise
in the level of the leaked molecules seems to be due to
an  increase  in  the  membrane  permeability.  The  mem‐
brane permeability of the bacteria is dictated by the outer
lipopolysaccharide  (LPS)  membrane.  The  altered  outer
LPS membrane structure exhibited increased permeabili‐
ty in E. coli [24]. Li’s group found that the silver nanopar‐
ticles  were  inhibiting  the  activity  of  respiratory  chain
dehydrogenases  in  a  concentration-dependent  manner.
The  AgNP-treated  bacterial  cells  were  significantly
deformed and fragmented. In addition, many of the cells
exhibited large gaps in the cellular structure observed via
TEM. Figure 1 represents the AgNP’s function in bacterial
inhibition and the improvement of silver ion delivery to
the membrane and cytoplasm of the bacteria cells. Xiu et
al. suggest that silver nanoparticles may contribute in the
growth control of higher-order organisms [25].
The antibacterial activities of silver nanoparticles are
influenced by the morphology and size of the nanoparti‐
cles. Morones et al. utilized high-angled annular dark-field
microscopy (HAADF) and TEM to investigate the antibac‐
terial activity of silver nanoparticles, in the size range of 1–
100 nm, on Gram-negative bacteria [26]. Luria broth plates
treated with various concentrations (0, 25, 50, 75, 100
μg/ml) of nano-silver were prepared and introduced to 10
ml of a prepared E. coli bacterial culture. The interrelation
of the nano-particulates and E. coli was analysed by
measuring the optical density at 595 nm. The silver
nanoparticles’ electrochemical nature was analysed by
using stripping voltammetry. The TEM confirmed that the
sizes of nanoparticles were between 1–10 nm. The majority
of particles with diameters from 1 to 10 nm were octahedral,
decahedral, or multiple-twinned icosahedral in shape. The
study of the effects of different concentrations of AgNPs on
bacterial growth demonstrated that concentrations above
75 μg/ml inhibited the growth. Further TEM analysis
confirmed the presence of silver nanoparticles in the cell
membrane and inside the bacteria. The HAADF image
shows that the smaller-sized nanoparticles (5 nm) pro‐
duced enhanced bactericidal efficacy, thus supporting the
size dependence of the activity of silver nanoparticles.
Panacek et al. synthesized silver nanoparticles varying in
size, via a one-step reaction (Tollens process) [27]. In this
method, different reducing agents (saccharides, glucose,
galactose, maltose and lactose) were used. The concentra‐
tion of AgNO3 (10-3 mol L-1) and reducing agents (0.01 mol
L-1)were fixed, and varying amounts of ammonia were
used from 0.2 to 0.005 mol L-1. A NaOH solution was used
to initiate the reduction of [Ag(NH3)2]+. The silver colloid
particles ranged in size from 25 to 100 nm, on average. This
size variation was dependent on the ammonia concentra‐
tion and on the type of reducing agent in the reaction
system. The ammonia concentration was significant in
defining the size of silver particles,since an increase in the
ammonia concentration increased the particle size. The size
Figure 1. Schematic representation of the improved silver ion delivery
capability of silver nanoparticles formed with natural ligands. The pH
difference between the cytoplasm and the membrane of the bacterial
components enhances the delivery of the active substances. Reprinted with
permission from Xiu, Z.-M., Q.-B. Zhang, H. L. Puppala, V. L. Colvin & P. J.
J. Alvarez (2012) Negligible Particle-Specific Antibacterial Activity of Silver
Nanoparticles. Nano Lett, 12, 4271–4275. Copyright © 2012 American
Chemical Society.
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transition from tens to hundreds of nanometres took place
when the ammonia concentration was at 0.035 mol L-1.
Additionally, the structures of saccharides influence the
size of AgNPs. Disaccharides (maltose) were efficient in the
reduction of [Ag(NH3)2]+ and produced monodispersed
particles with an average size of 25 nm. These sizes were
efficient (1.69 μg/mL of Ag) in inhibiting the bacterial
growth against both Gram-positive and Gram-negative
bacteria, including Staphylococcus aureus.The synthesized
particles were characterized by DLS, TEM and UV-visible
absorption spectrometry. Silver colloid nanoparticles with
an average size of 25 nm were produced by reducing
[Ag(NH3)2]+ with maltose. Through antimicrobial and
bactericidal assays, it was found that 25-nm silver colloid
particles demonstrated noticeable antimicrobial and
bactericidal activity against multi-resistant bacteria
species, including methicillin-resistantStaphylococcus
aureus (MRSA). Martínez-Castañón et al. investigated the
controlled formation of AgNPs at varying sizes(7, 29 and
89 nm) [28]. In this article, gallic acid was used to reduce
and stabilize the AgNPs. Through TEM analysis, the silver
nanoparticles were determined to be spherical at sizes 7
and 29 nm, and pseudo-spherical at 89 nm. The pH
adjustment of the reactions dictated the size of the silver
nanoparticles produced. The reduction at pH 11 and 10
resulted in 7-and 29-nm silver nanoparticles, respectively.
The reaction mixture was irradiated with UV light (254 nm,
25 W) for 30 minutes, in order to yield 89-nm AgNPs. The
solution was then heated for 30 minutes at 80⁰C. The
antibacterial activities of the silver nanoparticles weretest‐
ed against E. coliand S. aureus for comparison. Seven-
nanometre AgNPs showed the greatest antibacterial
activity against S. aureus and E. coli. Because of their
miniscule nanoparticle size (7 nm) and high surface area,
silver nanoparticles with 7 nm were able to easily reach the
nuclear content of the test subjects,thereby killing the
bacteria more efficiently. Espinosa-Cristóbal et al. investi‐
gated the antibacterial activity of AgNPs against Strepto‐
coccus mutans, a microorganism associated with dental
caries [29]. In this study, 8.4-, 16.1- and98-nmsilver nano‐
particles were prepared using an adaptation of the synthe‐
sis method reported by Martínez-Castañón et al. The
morphology of theS. mutans before and after their treat‐
ment with the AgNPs was surveyed via atomic force
microscopy (AFM). The AgNPs determined to have an
average diameter of 8.4 nm showed improved antibacterial
activity compared with those of the larger nanoparticles
(16.1 and 98 nm). Espinosa-Cristóbal et al. suggest that
smaller nanoparticles release more Ag+ ions, which leads to
an increase in their antibacterial effect. Lu et al. have also
reported the size-dependent nature of the antibacterial
activities of silver nanoparticles against anaerobic microbes
[30]. The antibacterial activities of the differently sized
AgNPs, synthesized by reduction, were evaluated by
colony counting assays, the growth inhibition curve
method, and corresponding minimum inhibitory concen‐
tration (MIC) measurements, against five anaerobic oral
pathogenic bacteria (Actinobacillus actinomycetemcomitans,
Fusobacterium nuceatum, Streptococcus mutans, Streptococcus
sanguisand Streptococcus mitis) and one aerobic bacteria (E.
coli). All three sizes were synthesized differently: the 5-nm
AgNPs were synthesized by adding AgNO3 (0.5 mL, 0.2 M)
to poly(N-vinyl-2-pyrrolidone) (PVP, MW & 55000), and
stirring in a round-bottom flask which contained 5 mL of
deionized water. After 30 minutes, a 0.1 M NaBH4 solution
was added to reduce the Ag+.TEM images revealed the size
of the AgNPs as 5 nm. Similarly, 15-nm AgNPs were
synthesized by adding 0.5 mL AgNO3 (0.05 M) to a flask
containing PVP (0.25 g) and 2- [4-(2-Hydroxyethyl)-1-
piperazinyl]ethanesulfonic acid (HEPES) buffer (25 mL,
100 mM, pH 7.4). After 30 minutes, NaBH4 (0.1 M) was
added to reduce the silver ions.Larger AgNPs (55 nm) were
prepared under a higher temperature, using PEG as a
reducing agent. The antibacterial effects of the particles
against anaerobic bacteria were lower than those against
aerobic bacteria. Thus, it can be inferred that bacteria
requiring oxygen for their survival are more susceptible to
AgNPs than those bacterial species that survive independ‐
ently of O2 presence. The 5-nm AgNPs presented the best
antibacterial activity against E. coli and F. nuceatum.
Considering the higher antimicrobial properties and lower
toxicity of AgNPs, compared to those of Ag compounds
such as AgNO3 and silver sulfadiazine, they could be used
for the treatment of periodontal pathogens with greater
benefits. Recently, Agnihotri et al. reported the size-specific
(5, 7, 10, 15, 20, 30, 50, 63, 85 and 100 nm) antibacterial
efficacy of silver nanoparticles [31]. These particles were
synthesized using NaBH4 as the primary reductant and
trisodium citrate as the co-reducing agent, under two
different thermal conditions. In stage I, metal salts were
reduced using NaBH4and the reaction mixture was
maintained at 60˚C. During this stage, reduction occurs,
and a large number of AgNPs are formed. In stage II, the
formed AgNPs undergo a growth process involving
further reduction, with the trisodium citrate and at a higher
temperature (90˚C). However, it was suggested that the
trisodium citrate remained passive during stage I, as it
prevented AgNPs from agglomerating. Furthermore, the
results suggested that NaBH4was important for the
formation of smaller-sized particles (5–20 nm),whereas
trisodium citrate was responsible for the yield of bigger
nanoparticles (60–100 nm), as shown in Figure 2.
From the results, the antibacterial efficacies of the silver
nanoparticles with diameters smaller than 10 nm were
significantly enhanced, as revealed through disc diffusion
tests, corresponding MIC/minimal bactericidal concentra‐
tion (MBC) values, and delayed bacterial growth kinetics.
The 5-nm AgNPs (the smallest) demonstrated the quickest
bactericidal activity on every test strain (E. coli MTCC 443,
E. coli MTCC 739, B. subtilis MTCC 441, and S. aureus
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 NCIM5021) compared to the 7-nm and 10-nm AgNPs at
similar bacterial concentrations. In conclusion, the silver
nanoparticles synthesized in a size-controlled manner
exhibited broad-spectrum antibacterial activity in a size-
and dose-dependent manner. Song et al. studied the shape-
dependent bactericidal qualities of AgNPs [32]. Three
different shapes of AgNPs were prepared. Typically,
particles were prepared from equimolar concentrations
(0.001 M) of AgNO3 and sodium citrate, under boiling
conditions and in the presence of silver seed solution (3 ml).
Spherically shaped AgNPs were obtained using a citrate
reduction method. The rod-shaped and truncated triangu‐
Figure 3. EFTEM images of E. coli cells. (A) Untreated E. coli, with visible
flagella. (B) E. coli grown on agar plates, supplemented with Ag+ (AgNO3).
Arrows indicate partially damaged membranes. These cells are viable. (C)
E. coli treated with triangular silver nanoplates. Silver nanoparticles appear
as dark irregular pits on the cell surface. (D) E. coli treated with spherical
silver nanoparticles. (E) Enlarged image of part of the bacterial cell
membrane, treated with triangular silver nanoparticles. The cell membrane
is damaged in multiple locations. Pal S. et al. (2007) Does the Antibacterial
Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle?
A Study of the Gram-Negative Bacterium Escherichia coli.Appl Environ
Microbiol, 73, 1712–1720.
lar AgNPs were obtained via a seeded growth method.
Both the particle types were grown together by adding 5
ml of silver seeds to a solution containing AgNO3 (5 ml, 0.01
M), ascorbic acid (0.1 M, 10 ml) and CTAB (146 ml, 0.1 M).
Particle growth was accelerated by adding NaOH (1 ml, 1
M). After aging, the particles were purified by centrifuga‐
tion to separate the truncated triangular and rod-shaped
AgNPs. To measure the killing kinetics of nano-silver, agar
plates were inoculated with 100 μl of bacterial suspensions
and treated with various AgNP amounts, ranging from 1
to 100 μg, in order to determine the susceptibility of
bacteria to silver. The truncated triangular nanoparticles,
with a total silver content of 10μg, led to the complete
hindrance of microbial growth. The improvement in
antibacterial activity of the truncated triangular nanopar‐
ticles was based on the {111} lattice structure of the trun‐
cated triangular nanoplate. The truncated triangular
nanoplates exhibited greater silver reactivity properties,
due to their high-atom-density facets (such as {111}),
whereas the spherical and rod-shaped nanoparticles
contained a greater level of {100} facets compared to {111}
facets. Therefore, it can be inferred that the high-atom-
density of the truncated triangular silver nanoparticles’
{111} lattice system enhances its antibacterial efficacy. The
shape dependence of the bactericidal qualities of the
AgNPs was supported by the results of the explored study.
Furthermore, the differences in the bactericidal activity of
differently shaped AgNPs were confirmed by EFTEM
(Figure 3). The EFTEM pictures demonstrated alterations
of the cell membrane that resulted in lysis. This shows that
triangular nanoparticles displayer better bactericidal
activity compared to spherical and rod-shaped nanoparti‐
cles, suggesting that the {111} lattice plane of triangular
nanoparticles was in better contact with the bacteria cell
wall, and thus able to cause more damage.
Figure 2. The schematic representation of the two-step synthesis of size-dependent silver nanoparticles, using NaBH4 and sodium citrate reduction under two
different thermal conditions. Agnihotri, S., S. Mukherji & S. Mukherji (2014) Size-controlled silver nanoparticles synthesized over the range 5–100 nm using
the same protocol and their antibacterial efficacy. RSC Advances, 4, 3974–3983.Reproduced by permission of the Royal Society of Chemistry (RSC), on behalf
of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
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One of the major benefits of the development process of
nanoparticles is its capacity for modification. By varying
the synthesis method and conditions, certain nanoparticle
properties can be controlled as desired [31, 33, 34]. The size,
composition, structure and other physical parameters of
the silver nanoparticles significantly affect the properties of
AgNPs. Interestingly, the antibacterial efficiency of silver
can be tuned by changing its valency. Only a few reports
have shown that the higher the valency, the greater the
antibacterial activity. Djokic prepared high-valent silver
oxysalts and studied their antimicrobial activity against
Pseudomonas aeruginosa, Staphyloccus aureus and Candida
albicans microorganisms [35]. This study suggested that
oxidized silver oxysalts produce a greater rate of antibac‐
terial activity compared to that of its lower-valent salts.
Based on this concept, and taking advantage of the nano‐
sized silver and the high surface-to-volume ratio of
nanoparticles, novel silver complexes were developed as
nanoparticles. Song et al. prepared nanosized high-valent
silver-chlorhexidine complexes (Ag(III)CHX) using a
reverse microemulsion system. In general, all AgNPs have
Ag in a zero oxidation state; however, nanocrystalline
Ag(III)CHX is structurally and chemically different from
the conventional AgNPs. Furthermore, Ag(III)CHX
exhibited higher antibacterial activity against various
Gram-positive and Gram-negative bacteria species.
A silver(I) chlorhexidine complex was synthesized in an in
situ precipitation of the complex, from a weakly acidic
AgNO3 solution and chlorhexidine (CHX). Ag(II)CHX was
synthesized by the oxidation of Ag(I), followed by the
complexation of the oxidized metal with chlorhexidine, as
shown in Figure 4.
The antibacterial activities of the novel complexes were
assessed in vitro on four gram-positive (Enterococcus faecalis,
Propionibacterium acnes, Staphylococcus epidermidis, Staphy‐
lococcus aureus) and four gram-negative species (Pseudomo‐
nas aeruginosa, Klebsiella pneumonia, Citrobacter freundii,
Acinetobacter calcoaceticus). The developed silver complexes
were far more efficient in killing the tested bacteria and did
so at a much faster rate when compared to AgSD and
AgNO3. These improved bactericidal efficacies of the
polydiguanide complexes might be a result of the higher
availability of silver ions in the medium as a result of the
reduction in the deactivation of the silver ions. Modifying
the valency of the silver also seems to affect the antimicro‐
bial activity of the nanoparticles [35]. In an attempt to
prepare trivalent silver polydiguanide complex
(Ag(III)CHX) as nanoparticles, a reverse micro-emulsion
method was utilized as shown in Figure 5.Ag(III)CHX
nanoparticles were prepared using a microemulsion
























































Figure 5.The synthesis sequence for silver chlorhexidine nanoparticles in a reverse microemulsion. Reprinted with permission from Pal, 12 
S., E. J. Yoon, Y. K. Tak, E. C. Choi & J. M. Song (2009) Synthesis of Highly Antibacterial Nanocrystalline Trivalent Silver Polydiguanide. 13 
J Am Chem Soc, 131, 16147–55. Copyright © 2009 American Chemical Society. 14 
The antibacterial activities of the novel complexes were 15 
assessed in vitro on four gram-positive (enterococcus 16 
faecalis, propionibacterium acnes, staphylococcus epidermidis, 17 
staphylococcus aureus) and four gram-negative species 18 
(pseudomonas aeruginosa, klebsiella pneumonia, citrobacter 19 
freundii, acinetobacter calcoaceticus). The developed silver 20 
complexes were far more efficient in killing the tested 21 
bacteria and did so at a much faster rate when compared 22 
to AgSD and AgNO3. These improved bactericidal 23 
efficacies of the polydiguanide complexes might be a 24 
result of the higher availability of silver ions in the 25 
medium as a result of the reduction in the deactivation of 26 
the silver ions. Modifying the valency of the silver also 27 
seems to affect the antimicrobial activity of the 28 
nanoparticles [35]. In an attempt to prepare trivalent 29 
silver polydiguanide complex (Ag(III)CHX) as 30 
nanoparticles, a reverse micro-emulsion method was 31 
utilized as shown in Figure 5.Ag(III)CHX nanoparticles 32 
were prepared using a microemulsion system comprising 33 
water, dioctyl sulfosuccinate sodium salt(AOT) and 34 
heptane. The formation of AgNPs can be divided into 35 
four main steps: first, the oxidation of Ag+ to Ag3+; then, 36 
the stabilization of Ag3+ by complexation with CHX 37 
molecules, followed by the neutralization of pH with 38 
sodium bicarbonate (NaHCO3); and finally, nucleation 39 
and particle growth. The nanoparticles were analysed 40 
through transmission electron microscope analysis, X-ray 41 
photoelectron spectroscopy, and zeta potential 42 
measurements. The water in a micro-emulsion system 43 
provides a limited micro-environment for the formation 44 
of nanoparticles and plays a crucial part in tuning the 45 
dimensions of the Ag(III)CHX nanoparticles. The MIC, 46 
MBC, and IC50 values were measured using agar dilution 47 
and broth dilution methods on a variety of Gram-positive 48 
and negative bacteria species. The antimicrobial 49 
properties of the synthesized Ag(III)CHX were much 50 
greater than those of AgNO3, AgSD and CHX alone 51 
(Table 1). The most significant difference between the 52 
levels of bactericidal efficiency was exhibited on the 53 
Acinteobacter calcoaceticus,where the Ag(III)CHX 54 
outperformed AgNO3 by more than ten-fold. Although 55 
the mechanisms of the enhancement are poorly 56 
understood, the study clearly presents the increased 57 
antimicrobial strength of nanocrystalline silver’s high 58 
valency. An in vitro study of the concentration-dependent 59 
cellular responses induced by silver nanoparticles was 60 
performed on human fibrosarcoma (HT-1080) and human 61 
skin/carcinoma(A431) cells [37]. The morphology studies 62 
showed that exposure to AgNP concentrations ranging 63 
from 6.25 to 50 μg/mL caused the cells to become less 64 
polyhedral, more fusiform, shrunken and rounded. The 65 
IC50 values for the HT-1080 and A431, determined by XTT 66 
assays, were 10.6 and 11.6 μg/mL, respectively. Cells 67 
treated with concentrations around half the IC50 exhibited 68 
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salt(AOT) and heptane. The formation of AgNPs can be
divided into four main steps: first, the oxidation of Ag+ to
Ag3+; then, the stabilization of Ag3+ by complexation with
CHX molecules, followed by the neutralization of pH with
sodium bicarbonate (NaHCO3); and finally, nucleation and
particle growth. The nanoparticles were analysed through
transmission electron microscope analysis, X-ray photo‐
electron spectroscopy, and zeta potential measurements.
The water in a micro-emulsion system provides a limited
micro-environment for the formation of nanoparticles and
plays a crucial part in tuning the dimensions of the
Ag(III)CHX nanoparticles. The MIC, MBC, and IC50 values
were measured using agar dilution and broth dilution
methods on a variety of Gram-positive and negative
bacteria species. The antimicrobial properties of the
synthesized Ag(III)CHX were much greater than those of
AgNO3, AgSD and CHX alone. The most significant
difference between the levels of bactericidal efficiency was
exhibited on the Acinteobacter calcoaceticus,where the
Ag(III)CHX outperformed AgNO3 by more than ten-fold.
Although the mechanisms of the enhancement are poorly
understood, the study clearly presents the increased
antimicrobial strength of nanocrystalline silver’s high
valency. An in vitro study of the concentration-dependent
cellular responses induced by silver nanoparticles was
performed on human fibrosarcoma (HT-1080) and human
skin/carcinoma(A431) cells [37]. The morphology studies
showed that exposure to AgNP concentrations ranging
from 6.25 to 50 μg/mL caused the cells to become less
polyhedral, more fusiform, shrunken and rounded. The
IC50 values for the HT-1080 and A431, determined by XTT
assays, were 10.6 and 11.6 μg/mL, respectively. Cells
treated with concentrations around half the IC50 exhibited
oxidative stress through significant decreases in the levels
of glutathione and superoxide dismutase, and an escalation
in the level of lipid peroxidation. The DNA fragmentation
observed in the AgNP-treated group suggested the
apoptosis of the AgNP-treated cells.
Silver nanoparticles are often incorporated into wound
treatment systems to provide clinically desirable properties
and an ideal environment for rapid and effective healing.
One silver nanoparticle-based dressing, ActicoatTMFlex 3,
was tested on a fibroblast cell culture and a partial-
thickness burn patient to study its effects [38]. In this study,
the in vitro experiments showed that the AgNPs reduced
mitochondrial activity without causing skin cell lysis or
compromising the nuclear integrity of the skin cells,
according to the data obtained through cellular staining
techniques. The reduced mitochondrial activity in the
studied area of interest suggests a decrease in the presence
of bacteria, thus supporting the antibacterial activity of the
AgNPs. Skin biopsies of AgNP-treated patients were
analysed via TEM and inductively coupled plasma mass
spectrometry (ICP-MS). The results led to the conclusion
that AgNPs are released as aggregates and localized in the
cytoplasm of fibroblasts, have different distributions
within the upper and lower dermis, and do not cause any
noticeable cell death. The ability of AgNPs to reduce the
growth of bacteria at the area of interest without causing
any serious damage to the skin cells, as presented in this
article, sets the basis of silver’s clinical safety and antibac‐
terial activity. Tian et al. investigated the in vivo wound-
healing properties of topically delivered AgNPs, and
observed swift healing and enhanced scarring appearance
in a dose-dependent manner [39]. The samples of nano-
silver were coated on a wound dressing applied to the area
of interest. In the thermal injury mouse model from this
study, the average of the healing times of animals inocu‐
lated with AgNPs was much shorter than those of the
negative control group and AgSD treatment group. In
addition, the appearances of the healed areas of the AgNP-
treated groups were the most similar to that of normal skin,
whereas the silver sulfadiazine groups exhibited hypertro‐
phic scarring. Tian’s group also presented results suggest‐
ing improved antibacterial properties, compared to those
of antibiotics, through quantitative polymerase chain
reaction (PCR), immunohistochemistry, and proteomic
studies of the wound sites of the animals. The wound
dressing coated with nano-silver was significantly more
efficient in hindering bacterial growth at the wound site
than the silver sulfadiazine (AgSD) solution. The microor‐
ganism culture from the wound swabs exhibited bacterial
culture growth after three days in the AgSD-treated group
and after seven days in the AgNP-treated group. In a
separate study, silver nanoparticles were impregnated into
bacterial cellulose to provide it with antibacterial proper‐
ties [40]. Bacterial cellulose, an ideal wound dressing
material because it provides a moist environment at the
site, does not contain any bactericidal activity. Thus, silver
nanoparticles were prepared, analysed, and impregnated
inside the bacterial cellulose fibre by soaking the bacterial
cellulose membranes in 0.001 M of aAgNO3 solution and
then reducing the silver ion-saturated bacterial cellulose
pellicles with various concentrations of aqueous NaBH4.
The freeze-dried silver nanoparticles-infused bacterial
cellulose was examined for its release of silver ions,
swelling, and antimicrobial activities. The results from the
disc diffusion method supported the successful infusion of
the AgNPs into the bacterial cellulose through the presen‐
tation of an inhibition zone, which the bacterial cellulose
alone did not exhibit. In terms of the bacterial growth
reduction of the silver nanoparticles-infused bacterial
cellulose, 99.7% and 99.9% reductions were observed
through colony forming count methods in E. coli and S.
aureus, respectively. Meanwhile, the pure bacterial cellu‐
lose groups exhibited 34.6% and 40.7% increase. This study
shows that AgNPs can be incorporated into biological
components without altering their properties (most
importantly, the clinically advantageous properties). Tang
et al. synthesized silver dendrimer nanocomposites with
diameters ranging from 9.5, 7.6 to 16.2 to 65 nm [41]. The
synthesized nanocomposites were used to prepare antibac‐
terial cotton fabrics as possible wound treatment utensils.
The silver-dendrimer nanocomposites were synthesized
using the following protocol: G2 dendrimer (1.9 mM) and
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methanol (30 ml) were first put into a conical flask and
stirred vigorously, to form a dendrimer-methanol solution
(10% w/w). To adjust the pH for better protonation, oxalic
acid (0.07 mol) was added, followed by an AgNO3
(1.9-0.96mM) solution. The reaction mixture was stirred for
two hours in the dark at room temperature. Finally, 10 ml
of a NaBH4 (0.95-0.048Mm) aqueous solution was added to
the above solution to reduce the metal ions. The reaction
mixture was stirred for another hour to yield the silver
nanocomposite solution. The antibacterial cotton fabric
was prepared by soaking the cotton fabric in the antibacte‐
rial agent solution (Ag-dendrimer nanocomposite+H2O,
pH8.0) for five minutes, stirring at room temperature, then
washing the cotton with deionized water and air-drying
the cotton. The antibacterial activity of the cotton fabric
containing dendrimer-encapsulated silver nanoparticles
was tested against S. aureus and E. coli through the inhibi‐
tion zone method. The authors’ results suggest that the
antibacterial activity of the silver nanocomposite cotton
fabrics was dependent on the size of the silver nanoparti‐
cles: the smaller the AgNPs, the larger the zone of inhibi‐
tion. The application of poly(amidoamine) (PAMAM)
dendrimers has been explored in numerous ways, includ‐
ing in gene transfection, the delivery of drugs, and bacterial
growth inhibition. Its wide range of uses stems from the
fact that PAMAM possesses exclusive properties, such as
large molecular size, well-defined molecular structure and
narrow size distribution. Strydom et al. recently studied the
PAMAM dendrimer with sulfadiazine (SD), for which its
silver nanoparticle complex was synthesized [42]. The
novel dendrimer complex showed high antibacterial
activity and improved water solubility compared with the
gold standard for the topical treatment of burn wounds:
silver sulfadiazine (AgSD). The nanoparticle complex was
prepared by utilizing a microfluidization method; the
particle size was characterized by DLS and the morphology
determined by TEM. To prepare the AgSD nanoparticles,
the authors followed a method previously used for silver-
dendrimer complex. In this method, 10ml of AgNO3
solution was added to the PAMAM dendrimer (10 ml) and
irradiated with UV light at different time intervals [43]. To
obtain a sulfadiazine-dendrimer (SD-dendrimer) complex,
a method developed by Prieto et al. was followed. To
synthesize the SD-dendrimer complex, the dendrimer and
SD were first dissolved in methanol at different molar
ratios. Then, these solutions were incubated for 45 minutes
at room temperature. The methanol was removed to obtain
a solid product, which was then dissolved in a buffer
solution and centrifuged to obtain the soluble SD-dendrim‐
er complex. In this method, equimolar solutions of Ag/
G4.0,G5.0-PAMAM-NH2 complex and SD/G3.5, G4.5-
PAMAM-COOH complex were mixed, and the silver
sulfadiazine complex was produced as a precipitate. This
method was scaled up using a modified microfluidizer
process. Structural analysis was performed using X-Ray
powder diffraction and Raman spectroscopy. The antibac‐
terial efficacy was determined against commonly found
burn wound bacteria:S. aureus, S. epidermis, P. auroginosa
and E. coli. The authors also studied the drug release
kinetics of the material and observed that the synthesized
antibiotic nanoparticles exhibited greater release rates,
compared to those of commercially available silver sulfa‐
diazine (AgSD) products. The efficient release rates of the
dendrimer-coated AgSD nanoparticles may be responsible
for the greater antibacterial activity in the burn wound
bacterial culture exhibited by the novel nanomaterial.
Silver is mostly known for its indirect contribution to
wound care, by aiding in the removal and preventing the
presence of unwanted materials at the wound site; howev‐
er, recent studies have been shedding light on the unpre‐
cedented properties that contribute advantageously to
damage repair. Liu et al. investigated how the AgNPs
influence specific cells during the wound healing process
[44]. The cellular response of keratinocytes and fibroblasts
(the cell types involved in dermal contraction and epider‐
mal re-epithelialization), from an excisional wound model
in rodents, were studied in this article. The wound con‐
traction rate was determined by measuring the wound site
area over time. The wound closure process of the AgNP-
treated group displayed an accelerated rate. A histological
study of the epithelial tongue growth, using an immuno‐
histochemistry stain to measure cell division, confirmed a
significant increase in cell proliferation in the AgNP-
treated groups. The authors concluded that the AgNPs
promoted re-epithelialization through increased keratino‐
cyte migration and proliferation, and wound contraction,
by driving the differentiation of fibroblasts into myofibro‐
blasts. These mechanistic explanations of the AgNPs’
wound healing promotion illuminate possible methods for
further improving wound care efficiency, by shortening the
healing time of the wound site. AgNPs were reported to
affect both local and systemic inflammation, as shown in
Figure 6(A) [39]. Tian et al. also studied burn injury sites
via proteomic analyses, to monitor the expression levels of
major acute-phase proteins: haemopexin (Hpx), haptoglo‐
bin (Hpg), and serum amyloid protein component P (SAP).
The plasma glycoproteins—Hpx and Hpg—bind to
haemoglobin and free haeme, which are released during
intravascular haemolysis to defend against oxidative
damage. Figure 6(B) exhibits the silver nanoparticles’ (ND)
ability to normalize the expression levels of the acute-phase
proteins to the levels exhibited by normal skin, faster than
untreated and silver sulfadiazine- (SSD-)treated skin. The
levels of cytokines involved in the dermal injury repair
process (including IFN-γ, VEGF, TGF-β1, IL-6, and IL-10)
were affected by the presence of AgNPs [39]. Cytokine
modulation of the silver nanoparticles was investigated
using quantitative real-time PCR. The IFN-γ, VEGF, and
IL-10levels of the AgNP-treated groups were higher than
those exhibited in the AgSD-treated groups, while IL-6
mRNA levels of the AgNP group was significantly lower.
The cytokine expression modulation of the silver nanopar‐
ticles was dose-dependent. The changes in the levels of the
different cytokines suggested a method of controlling
specific molecules, which could lead to a greater under‐
standing of wound healing and its dose-dependent
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interaction with foreign materials. Nadworny et al. report‐
ed that nano-silver reduced inflammation when tested on
a porcine model of contact dermatitis [45]. The area of
interest was treated with silver nanoparticle dressings,
0.5% silver nitrate, or saline solutions. Among the experi‐
ment groups, the skin treated with silver nano dressing was
the closest to healthy skin, according to the erythema and
oedema examinations and histological data. The authors
concluded that the decreased inflammation was associated
with a rise in the degree of inflammatory cell apoptosis and
a decrease in the expression of pro-inflammatory cytokines
and gelatinase activity. Silver nanoparticles were also
successful in reducing inflammation in different forms.
Nanocrystalline silver was reported to significantly reduce
the colonic inflammation caused by ulcerative colitis in
mice [46]. The intracolonically or orally administered silver
nanoparticles significantly restrained the expression of
tumour necrosis factor-alpha (TNF-α), matrix metallopro‐
teinase-9 (MMP-9), interleukin-1beta (IL-1β), and IL-12. In
another study, different concentrations of nanocrystalline
silver (NCS) were intravesically administered to rats as a
possible treatment for interstitial cystitis [47]. Boucher et al.
aimed to assess the anti-inflammatory qualities of AgNPs
by studying the bladders and urine of silver nanoparticle-
treated rats. The urine of the subjects was collected
throughout the treatment period and the bladder was
obtained from the rats after the four-hour treatment period.
The histamine levels of the NCS-treated rats were reduced
compared to those of the PBS-treated rats. The histamine
and TNF-α levels released from the bladder explants were
lower in the rats treated with NCS. These studies support
silver nanoparticles’ ability to reduce inflammation: a
crucial aspect in encouraging wound healing via a more
direct approach.
4. Modified Silver and Silver Nanoparticles
One of the major benefits of the development process of
nanoparticles is its capacity for modification. By varying
the synthesis method and conditions, certain properties of
the nanoparticles can be controlled as desired [31, 33, 34].
The size, composition, structure and other physical
parameters of the silver nanoparticles significantly affect
the properties of AgNPs. Furthermore, the conjugation of
AgNPs is possible, depending on the composition of the
nanocrystalline silver, which makes AgNPs much more
versatile.
Song et al. developed multifunctional composites compris‐
ing the dual properties of antibacterial activity and wound
healing [48]. In this work, a bi-valent silver polydiguanide
was conjugated to histatin-1 (HST-1): a known potent
wound-healing polypeptide. HST-1 is known to be a major
factor in wound closure. Its induction of wound closure
stems from its ability to be actively internalized by epithe‐
lial cells, to enhance epithelial migration using the extrac‐
ellular signal-regulated kinases 1/2 (ERK1/2) pathway [49].
Solid-phase peptide synthesis, utilizing Fmoc chemistry
with an automatic peptide synthesizer, was carried out to
yield the linear peptide HST-1. The product was then
purified using RP-HPLC and characterized using mass
spectrometry (MS). Ag(II)CHX, known for its enhanced
bactericidal activity, was synthesized using a previously
established procedure. The formed Ag(II)CHX was then
dissolved in DMSO and conjugated with HST-1 at different
ratios. The reaction mixtures were incubated at 2–8˚C for
one hour. The various peptide-metal complex solutions
were then stored at 2–8˚C for one month, before being
tested for their antibacterial activity and used in cell-
spreading assays. Circular dichroism spectroscopy was
used to confirm the formation of the HSt-1- [Ag(II)CHX]
complex. The antibacterial properties of the novel poly‐
peptide complex were measured by calculating its MICs
and MBCs on four strains of Gram-negative bacteria
(Pseudomonas aeruginosa, Klebsiella pneumonia, Citrobacter
freundii and Acinetobacter calcoaceticus) and four strains of
Gram-positive bacteria (Propionibacterium acnes, Staphylo‐
coccus epidermidis, Staphylococcus aureus and Enterococcus
faecalis). The MICs and MBCs of Ag(II)CHX were compared
to those of the Hst-1- [Ag(II)CHX]. The MICs and MBCs of
the Hst-1- [Ag(II)CHX] were slightly higher than those of
the Ag(II)CHX, but seemed to retain a large part of the
starting material’s antibacterial activity. Furthermore, the
wound-healing properties of the synthesized complex
were studied using cell-spreading assays, as shown in
Figure 7. The in vitro cell-spreading assay was prepared by
preparing and culturing 3T3-L1 cells, with a cell-free gap
in the centre. The samples were treated with the different
substances to test their cell migration-enhancing abilities.
The relative cell-free gaps (RGt) were calculated at different
time intervals (0, 12, and 24 hours), in order to compare the
wound-healing properties of the novel polypeptide silver
complex. As shown in Figure 7, the Ag(II)CHX-treated
samples did not exhibit much cell migration promotion,
while both the HST-1- and HST-1- [Ag(II)CHX]-treated
cells exhibited much smaller cell-free gap areas, compared
to that of the control after 12 hours. The promotion of cell
migration, shown in the materials consisting of polypep‐
tide or polypeptide-conjugated complexes, show that the
silver nanoparticles can be conjugated with desired
properties, in order to aid in the treatment of wounds.
5. Conclusion
In various different forms, silver is capable of aiding the
wound healing process, mainly through its antibacterial
activity. The broad spectrum of the silver ion’s antibacterial
activity—a result of the multiplicity of the bactericidal
mechanism—has proven itself to be effective on a variety
of bacteria species in multitudinous studies. Although
silver has already been incorporated into commercially
available products, the advancement of such wound care
would have positive implications for the health and
economy of humanity, especially if the less developed
countries were granted an increased access to such medical
necessities. Through the development of nanoparticles,
and their modification at the molecular and nano level, the
application efficiency of wound treatments containing
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silver has been improving noticeably. These developments
may be able to significantly reduce the time required for the
wound area to reach its normal homeostatic equilibrium,
while reducing the risk of unwanted complications and
improving the physical appearance of the scar by reducing
hypertrophic scarring. While seemingly effective and safe,
the safety of such materials should always be investigated
thoroughly. By proceeding with punctiliousness, and
studying its versatility and its limits, silver may be used to
provide the medical community with a new generation of
highly effective and multi-dimensional wound treatment
systems.
Figure 6. (A) Neutrophil immunohistochemical microscopy images of ND (silver nanoparticles), SSD (silver sulfadiazine), and negative control groups, using
naphthol ASD chloroacetate esterase. (B) Images monitoring the expression of proteins and serum markers, in burn injuries. The proteins were analysed using
2D electrophoresis and MALDI-TOF MS protein identification. Tian, J., K. K. Wong, C. M. Ho, C. N. Lok, W. Y. Yu, C. M. Che, J. F. Chiu & P. K. Tam (2007)
Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem, 2, 129–36.Reprinted with permission from ChemMedChem.
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